Crafting a Rigorous, Clinically Relevant Large Animal Model of Chronic Myocardial Ischemia: What Have We Learned in 20 Years?

Author:

Stone Christopher R.1,Harris Dwight D.1,Broadwin Mark1,Kanuparthy Meghamsh1,Sabe Sharif A.1ORCID,Xu Cynthia1,Feng Jun1,Abid M. Ruhul1,Sellke Frank W.1

Affiliation:

1. Department of Cardiothoracic Surgery, The Warren Alpert School of Medicine at Brown University, Providence, RI 02903, USA

Abstract

The past several decades have borne witness to several breakthroughs and paradigm shifts within the field of cardiovascular medicine, but one component that has remained constant throughout this time is the need for accurate animal models for the refinement and elaboration of the hypotheses and therapies crucial to our capacity to combat human disease. Numerous sophisticated and high-throughput molecular strategies have emerged, including rational drug design and the multi-omics approaches that allow extensive characterization of the host response to disease states and their prospective resolutions, but these technologies all require grounding within a faithful representation of their clinical context. Over this period, our lab has exhaustively tested, progressively refined, and extensively contributed to cardiovascular discovery on the basis of one such faithful representation. It is the purpose of this paper to review our porcine model of chronic myocardial ischemia using ameroid constriction and the subsequent myriad of physiological and molecular–biological insights it has allowed our lab to attain and describe. We hope that, by depicting our methods and the insight they have yielded clearly and completely—drawing for this purpose on comprehensive videographic illustration—other research teams will be empowered to carry our work forward, drawing on our experience to refine their own investigations into the pathogenesis and eradication of cardiovascular disease.

Publisher

MDPI AG

Reference92 articles.

1. (2023, November 20). Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association. Available online: https://www.ahajournals.org/doi/10.1161/CIR.0000000000001123.

2. (2023, November 20). Mortality in the United States, Available online: https://stacks.cdc.gov/view/cdc/112079.

3. The Global Burden of Cardiovascular Diseases and Risk;Vaduganathan;J. Am. Coll. Cardiol.,2022

4. Therapeutic Approaches for the No-Option Refractory Angina Patient;Povsic;Circ. Cardiovasc. Interv.,2021

5. Aribindi, S., Jiang, J., Shaikh, U., and Hidad, A. (2023). Cardiac Stem Cell–Derived Treatment for Ischemic Heart Disease: A Review. Georget. Med. Rev., 7.

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3